Aligos Therapeutics Inc Cash Flow Quality Index

Latest as of March 2025: -0.49x

Aligos Therapeutics Inc cash flow quality index. Aligos Therapeutics Inc (ALGS) has a Cash Flow Quality Index of -0.49x as of March 2025. Operating cash flow of $-20.91 Million is below net income of $43.09 Million, suggesting accrual-heavy earnings not yet converted to cash. See ALGS financial flexibility score to measure the company's free cash flow as a share of total liabilities.

Cash Flow Quality Index

-0.49x

Operating CF / Net Income

Operating Cash Flow

$-20.91 Million

USD

Net Income

$43.09 Million

USD

Data as of

Mar 2025

Most recent filing

Aligos Therapeutics Inc Cash Flow Quality Index by Year (None–None)

Aligos Therapeutics Inc cash flow quality index by year from None to None. Year-by-year earnings quality comparison for Aligos Therapeutics Inc. For the full cash flow conversion analysis, see ALGS cash flow conversion.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.